1,2,3,4,6-pentakis-O-galloyl-beta-D-glucose has been researched along with trinitrobenzenesulfonic acid in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Han, MJ; Hyam, SR; Jang, SE; Jeong, JJ; Kim, DH | 1 |
1 other study(ies) available for 1,2,3,4,6-pentakis-O-galloyl-beta-D-glucose and trinitrobenzenesulfonic acid
| Article | Year |
|---|---|
Penta-O-galloyl-β-D-glucose ameliorates inflammation by inhibiting MyD88/NF-κB and MyD88/MAPK signalling pathways.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents; Cells, Cultured; Colitis; Colon; Disease Models, Animal; Dose-Response Relationship, Drug; Gastrointestinal Agents; Hydrolyzable Tannins; Inflammation Mediators; Interleukin-1 Receptor-Associated Kinases; Macrophages, Peritoneal; Male; MAP Kinase Signaling System; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinases; Molecular Sequence Data; Myeloid Differentiation Factor 88; NF-kappa B; Phosphorylation; RNA Interference; Toll-Like Receptor 4; Transfection; Trinitrobenzenesulfonic Acid | 2013 |